MIMEDX Group, Inc.

Home
United States
Atlanta, GA
MIMEDX Group, Inc.

Patients are why we are here. MIMEDX has supplied over two million allografts, through both direct and consignment shipments.

MIMEDX is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, we have both a core business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION® process. We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts. For additional information, please visit www.mimedx.com.

02/04/2026

Precision matters in PRP preparation. RegenKit®-Wound Gel is a fully autologous PRP solution engineered to remove iron-laden red blood cells while concentrating key biological components within a natural fibrin scaffold.

It can be applied topically in two forms – as a wound gel or with a spray applicator. Contact us to get started: https://mimedx.info/Contact-Us

01/29/2026

Just the facts on the 2026 MPFS Final Rule. Join us for JUST THE FACTS, an on-demand WEBINAR with Kathleen Schaum, for practical guidance on preparing for the year ahead.

Prepare with facts. Register today: https://mimedx.info/Just-The-Facts-PFS-On-Demand

01/28/2026

Wound care is evolving, and so are the policies that govern it. With Medicare no longer covering wasted product, efficiency is essential. MIMEDX offers solutions that fit. Our size-specific allografts help clinicians deliver optimal care while reducing unnecessary costs.

See how we’re helping you redefine wound care: https://mimedx.info/Contact-Us

01/27/2026

Wondering how the new MPFS impacts your wound care practice? Kathleen Schaum explains what matters most. This episode of JUST THE FACTS delivers a fact-based look at coding, payment, and compliance considerations for skin substitutes.

Just the facts, now on demand. Register now: https://mimedx.info/Just-The-Facts-PFS-On-Demand

01/22/2026

Policy updates are reshaping wound care reimbursement. Oversized grafts can lead to unnecessary waste—and lost revenue.

MIMEDX provides a full portfolio of size-specific allografts, helping clinicians deliver efficient, cost-conscious care without compromising outcomes.

Learn why choosing the right size matters more than ever: https://mimedx.info/Contact-Us

01/21/2026

The 2026 MPFS Final Rule introduces important updates for skin substitute utilization.

In our second JUST THE FACTS installation, Kathleen Schaum answers common coding and payment questions and outlines practical steps to help practices stay compliant and prepared.

Clear guidance for 2026. Register now to watch on demand: https://mimedx.info/Just-The-Facts-PFS-On-Demand

01/15/2026

For hospital outpatient teams navigating OPPS changes, understanding the details matters.

Join Kathleen Schaum for JUST THE FACTS, an educational webinar unpacking the new ruling and what the policy language means in practice.

Facts over speculation. Register now to watch on-demand: https://mimedx.info/Just-The-Facts-OPPS-On-Demand

01/14/2026

Explore the latest casebook featuring real surgical applications of AMNIOEFFECT®, a tri-layer human placental allograft that provides a protective barrier to support the healing cascade.

Each case demonstrates AMNIOEFFECT's real-world outcomes in a variety of surgical applications. See the results for yourself: https://bit.ly/AMNIOEFFECT

01/08/2026

When policy changes, facts matter.
Join reimbursement expert Kathleen Schaum for JUST THE FACTS, an educational webinar focused on the new OPPS ruling—designed to help hospital outpatient teams better understand the policy language and considerations.

No speculation. Just the facts. Register to watch on January 14th, 2026, 12:00 PM EST: https://mimedx.info/JUST-THE-FACTS-OPPS

01/07/2026

For hospital outpatient teams navigating OPPS changes, understanding the details matters.

Join Kathleen Schaum for JUST THE FACTS, an educational webinar unpacking the new ruling and what the policy language means in practice.

⏱️January 14th, 2026 | 12:00 PM EST
Facts over speculation. Register now: https://mimedx.info/JUST-THE-FACTS-OPPS

01/06/2026

AMNIOEFFECT® is an advanced tri-layer placental allograft that provides a protective barrier to support the healing cascade. It is 3x thicker than a dual-layer amnion/chorion allograft to address surgical wounds and provide optimal handling.¹ The product is used in surgical wounds that include:
⬢Debridements
⬢Amputations
⬢Complex incision management
⬢Tendon & ligament repair

Explore where AMNIOEFFECT fits in your surgical toolkit: https://bit.ly/AMNIOEFFECT

1. MIMEDX Internal Report, MM-RD-00116.

01/02/2026

🏥 Rural and Critical Access Hospitals face unique challenges in diabetic care — but with the right strategies, they can lead the way in prevention and early intervention.

Join the National Rural Health Association (NRHA) and MIMEDX for a free educational webinar designed for hospital leaders, clinicians, and wound care teams.

🎙️Speaker: Anthony Iorio, DPM, FACFAS, FAPWHc
💻Register and watch here: https://mimedx.info/NRHA-Webinar

Address

Atlanta, GA

Telephone

+17706519100

Website

http://www.mimedx.com/

Alerts

Be the first to know and let us send you an email when MIMEDX Group, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Atlanta?